84 related articles for article (PubMed ID: 23101269)
1. Preoperative serum levels of soluble endoglin for prediction of recurrence in stage III colorectal cancer patients.
Gomceli I; Tez M; Bostanci EB; Turhan N; Kemik AS; Akoglu M
Acta Medica (Hradec Kralove); 2012; 55(2):74-7. PubMed ID: 23101269
[TBL] [Abstract][Full Text] [Related]
2. Is serum placental growth factor a prognostic marker for stage III colorectal cancer patients?
Gomceli I; Tez M; Bostanci EB; Ulas M; Turhan N; Kemik AS; Akoglu M
Hepatogastroenterology; 2012; 59(117):1437-40. PubMed ID: 22155858
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the preoperative serum levels of soluble form of endoglin in gastric cancer patients.
Gomceli I; Tez M; Bostanci EB; Kemik AS; Demiriz B; Akoglu M
Bratisl Lek Listy; 2013; 114(10):566-8. PubMed ID: 24156679
[TBL] [Abstract][Full Text] [Related]
4. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
[TBL] [Abstract][Full Text] [Related]
5. Combined perioperative plasma endoglin and VEGF-A assessment in colorectal cancer patients.
Myśliwiec P; Pawlak K; Kukliński A; Kedra B
Folia Histochem Cytobiol; 2008; 46(4):487-92. PubMed ID: 19141403
[TBL] [Abstract][Full Text] [Related]
6. Combined perioperative plasma endoglin and VEGF--a assessment in colorectal cancer patients.
Myśliwiec P; Pawlak K; Kukliński A; Kedra B
Folia Histochem Cytobiol; 2009; 47(2):231-6. PubMed ID: 19995709
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
8. Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin.
Takahashi N; Kawanishi-Tabata R; Haba A; Tabata M; Haruta Y; Tsai H; Seon BK
Clin Cancer Res; 2001 Mar; 7(3):524-32. PubMed ID: 11297243
[TBL] [Abstract][Full Text] [Related]
9. Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy.
Svatek RS; Karam JA; Roehrborn CG; Karakiewicz PI; Slawin KM; Shariat SF
Clin Cancer Res; 2008 Jun; 14(11):3362-6. PubMed ID: 18519764
[TBL] [Abstract][Full Text] [Related]
10. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
[TBL] [Abstract][Full Text] [Related]
11. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.
Takakura Y; Ikeda S; Imaoka Y; Urushihara T; Itamoto T
Colorectal Dis; 2015 May; 17(5):417-25. PubMed ID: 25512077
[TBL] [Abstract][Full Text] [Related]
12. Serum level of endothelial cell-specific molecule-1 and prognosis of colorectal cancer.
Jiang H; Fu XG; Chen YT
Genet Mol Res; 2015 May; 14(2):5519-26. PubMed ID: 26125749
[TBL] [Abstract][Full Text] [Related]
13. Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer.
Mallappa S; Sinha A; Gupta S; Chadwick SJ
Colorectal Dis; 2013 Mar; 15(3):323-8. PubMed ID: 22958479
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum concentration of monocyte chemotactic protein 4 (MCP-4) as a novel non-invasive prognostic and predictive biomarker for detection of metastasis in colorectal cancer.
Okugawa Y; Toiyama Y; Mohri Y; Tanaka K; Kawamura M; Hiro J; Araki T; Inoue Y; Miki C; Kusunoki M
J Surg Oncol; 2016 Sep; 114(4):483-9. PubMed ID: 27349356
[TBL] [Abstract][Full Text] [Related]
15. Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients.
Pappa CA; Alexandrakis MG; Boula A; Psarakis FE; Kolovou A; Bantouna V; Stavroulaki E; Tsirakis G
Hematol Oncol; 2013 Dec; 31(4):201-5. PubMed ID: 23576184
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer.
Katoh H; Yamashita K; Wang G; Sato T; Nakamura T; Watanabe M
Ann Surg Oncol; 2011 Sep; 18(9):2432-41. PubMed ID: 21369738
[TBL] [Abstract][Full Text] [Related]
17. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
Karam JA; Svatek RS; Karakiewicz PI; Gallina A; Roehrborn CG; Slawin KM; Shariat SF
Clin Cancer Res; 2008 Mar; 14(5):1418-22. PubMed ID: 18316564
[TBL] [Abstract][Full Text] [Related]
18. Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer.
Nogués A; Gallardo-Vara E; Zafra MP; Mate P; Marijuan JL; Alonso A; Botella LM; Prieto MI
World J Surg Oncol; 2020 May; 18(1):99. PubMed ID: 32434528
[TBL] [Abstract][Full Text] [Related]
19. Impact of C-reactive protein on prognosis of patients with colorectal carcinoma.
Takasu C; Shimada M; Kurita N; Iwata T; Nishioka M; Morimoto S; Yoshikawa K; Miyatani T; Kashihara H; Utsunomiya T
Hepatogastroenterology; 2013 May; 60(123):507-11. PubMed ID: 23635436
[TBL] [Abstract][Full Text] [Related]
20. Soluble angiogenesis markers in gastric tumor patients.
Mysliwiec P; Pawlak K; Bandurski R; Kedra B
Folia Histochem Cytobiol; 2009; 47(1):81-6. PubMed ID: 19419943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
